Amplification of EGFR T790M causes resistance to an irreversible EGFR inhibitor
Dalia Ercan(Dana-Farber Cancer Institute), Kreshnik Zejnullahu(Dana-Farber Cancer Institute), Kimio Yonesaka(Dana-Farber Cancer Institute), Yun Xiao(Brigham and Women's Hospital), Marzia Capelletti(Dana-Farber Cancer Institute), Andrew M. Rogers(Dana-Farber Cancer Institute), Eugene Lifshits(Massachusetts General Hospital), Alyssa Brown(Harvard University), Charles Lee(Brigham and Women's Hospital), James G. Christensen(Pfizer (United States)), David J. Kwiatkowski(Brigham and Women's Hospital), Jeffrey A. Engelman(Massachusetts General Hospital), Pasi A. Jänne(Brigham and Women's Hospital)
Cited by 227Open Access
Abstract
Related Papers
No related papers found
Powered by citation graph analysis